NCT01184326 Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer Status COMPLETED Phase PHASE1
NCT01182415 High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma Status COMPLETED Phase PHASE2
NCT01177527 Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01173679 Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL Status TERMINATED Phase PHASE2
NCT01167114 STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer Status COMPLETED Phase PHASE2
NCT01154920 Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01148056 Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer Status TERMINATED Phase NA
NCT01125293 Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia Status TERMINATED Phase PHASE1/PHASE2
NCT01112527 PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma Status COMPLETED Phase PHASE2
NCT01112514 Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract Status COMPLETED Phase NA
NCT01105988 Evaluating Tumor Pseudoprogression With FLT-PET and MRI Status TERMINATED Phase EARLY_PHASE1
NCT01096602 Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission Status COMPLETED Phase PHASE2
NCT01085201 Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT01078961 An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma Status COMPLETED Phase PHASE1
NCT01067287 Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT01066663 Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE1/PHASE2